US scrambles for resources in COVID-19 response
According to new IHS Markit data, the United States' shortage of medical supplies is being exacerbated by trade disruptions from…
NULL
-
-
Polish pharma associations unite in appeal for greater access to biologics
Poland's pricing and reimbursement system has always had a reputation for restrictiveness when it comes to originator therapies, with its…
-
Challenges with risk sharing in Eastern Europe raised at ISPOR Europe meeting
While attending the ISPOR Europe 2019 meeting in Copenhagen, I came across an interesting discussion of the unique challenges that…
-
Dynamic reform in International Reference Pricing
The same week that we recently aired our webinar on the impact and risks of international reference pricing (IRP), Slovakia…
-
ISPOR Europe 2018 Barcelona
We are at ISPOR Europe 2018 in Barcelona, Spain! We look forward to seeing you there! Please look out for…
-
HTA adoption in Asian emerging pharma markets
Asia's emerging markets - such as Indonesia, Vietnam, and the Philippines - may provide a significant growth opportunity of pharmaceutical…
-
Nevermore ignore the role of digital health in health decision making
Here at the opening of the 23rd annual international meeting of ISPOR in Baltimore - 10 years after we started attending…
-
Value in healthcare: Insights from ISPOR
I am just back from beautiful Glasgow where this week you could see Roger Federer play in a kilt and…
-
Better diabetes treatment can save Medicaid over $4 billion per year
Diabetes is one of the most prevalent and expensive medical conditions in the US, especially among people with low socio-economic…
-
Visit us at ISPOR 2017 Glasgow!
We are pleased to announce that we will be at the 20th Annual ISPOR European Congress, 4-8 November, in Glasgow.…
